Board of Directors

Mr. Samson, founder and CEO of Samson Medical Technologies and Chairman of the Board of Trustees of the University of the Sciences, was formerly a Group Vice President - Worldwide Injectables of Teva, previously having served as CEO and a member of the Board of Directors of Sicor (acquired in 2004 by Teva for $3.4 billion). He was also the CEO of Qualitest Pharmaceuticals. He is an expert in injectable manufacturing and delivery systems and was a founder and CEO of Elkins-Sinn (today, West-Ward Pharmaceuticals, one of the largest generic injectables companies in the U.S.) and Marsam Pharmaceuticals.

Quintin J. Lai, Ph.D., CFA serves as Vice President, Corporate Development, Strategy and Investor Relations at West Pharmaceutical Services.

Prior to joining West, Dr. Lai served as Vice President of Investor Relations and Corporate Strategy at Sigma-Aldrich Corporation, where he was responsible for developing a global strategy for that S&P 500 company as well as creating an industry-leading IR function. From 2002-2012, Dr. Lai served as Managing Director and Senior Equity Research analyst of the Life Science Tools and Diagnostic sector at Robert W. Baird & Company. He also spent eight years as a Senior Research Engineer at Atlantic Richfield (ARCO).

Dr. Lai holds a Bachelor of Science degree in Chemical Engineering from the University of Alabama, a doctoral degree in Chemical Engineering from the University of Wisconsin-Madison and a Masters of Business Administration degree from the University of Chicago Booth School of Business.

Dr. Ron is a physician and attorney. She has extensive medical, legal and management experience in insurance companies, law firms, medical and educational institutions. Her legal and management expertise includes venture capital consulting, medical malpractice, general and medical insurance and legal practice. Hadar holds an MD from the Sackler School of Medicine, Tel Aviv University, and an LL.B. in Law from Tel Aviv University.

CEO of Elcam Medical ACS Ltd., a leading worldwide OEM supplier, servicing the medical industry in the area of Fluid Management, Vital Signs Monitoring and Drug Delivery, and the chairman of Elcam Medical US. Igal was Elcam Medical C.F.O since 1998 and holding Israeli CPA.  

Since January 2020, Mr. Stoffman is co-managing XT Hi-Tech, the venture capital arm of the global shipping & industrial group XT Holdings. Between 2012 and June 2018, Mr. Stoffman was the co-founder and CEO of MValve Technologies Ltd, pioneering a revolutionary concept in treating mitral valve disease. Prior to MValve, between 2009 and 2012 Mr. Stoffman served as Executive Vice President of XT Hi-Tech, in charge of software and healthcare investments. Mr. Stoffman was the founding investor and executive chairman of Checkmarx (acquired by Insight Venture Partners), and served on the board of directors of JetPrep (acquired by Cantel Medical; NYSE: CMD), CmyCasa (acquired by Adobe; NASDAQ: ADBE) and Activiews (acquired by Stryker; NYSE:SYK). Between 2004 and 2008 Mr. Stoffman was the CEO of Naiot Venture Accelerator, a leading healthcare and software accelerator, where he was leading the foundation of numerous start-up companies. Mr. Stoffman holds an LL.M. (negotiations and dispute resolution) degree from Bar-Ilan University and LL.B. and BA (Business Administration) degrees from the Interdisciplinary Center, Herzliya.  

Dr. Yeshurun brings two decades of MEMS and advanced materials R&D expertise to NanoPass. His work integrates both commercial and academic experience. Dr. Yeshurun has an established history in bringing multi-million dollar technology-intensive projects from a concept to the market. Dr. Yeshurun earned his B.Sc. in Mechanical engineering at the Beer Sheva University, and his M.Sc. and PhD in Advanced Materials at the Technion Institute of Technology. A prolific scholar, Dr. Yeshurun has authored over 40 professional publications and 50 classified reports. He is a lecturer at the Technion Institute. A Senior Scientist at NATIONAL LAB, Dr. Yeshurun was a group leader in charge of developing piezoelectric materials for MEMS applications. Dr. Yeshurun holds over a dozen patents and was awarded the American Ceramic Society “Rose” Award for his work. He serves as member of the Board of Directors.